Journal article
Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People
JAMA cardiology, Vol.7(11), pp.1170-1174
10/05/2022
DOI: 10.1001/jamacardio.2022.3299
PMCID: PMC9535541
PMID: 36197689
Abstract
ImportanceSex-specific differences in the commonly used cardiac biomarkers high-sensitivity cardiac troponin (hs-cTn) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are apparent. There is an absence of medical literature delineating the concentration differences for these biomarkers in transgender individuals without cardiac disease. ObjectiveTo determine the distribution of hs-cTn and NT-proBNP in healthy transgender people. Design, Setting, and ParticipantsIn this cross-sectional prospective study, healthy transgender individuals prescribed testosterone or estradiol for 12 months or more were recruited from internal medicine and primary care clinics that specialize in transgender medical care between November 1, 2017, and July 1, 2018. ExposuresTestosterone or estradiol for 12 months. Main Outcomes and MeasuresConcentrations for hs-cTnI (troponin I), hs-cTnT (troponin T), and NT-proBNP were measured. ResultsTransgender people prescribed testosterone (n = 79; mean [SD] age, 28.8 [7.8] years) or estrogen (n = 93; mean [SD] age, 35.1 [11.7] years) were recruited. The concentration of hs-cTn was significantly higher in transgender men relative to transgender women. For Abbott hs-cTnI levels, the median (IQR) concentration observed in transgender men and women was 0.9 (0.6-1.7) ng/L and 0.6 (0.3-1.0) ng/L, respectively. Results were similar across 2 additional hs-cTn assays. In contrast, NT-proBNP level was higher in transgender women. The median (IQR) NT-proBNP concentration was significantly higher in transgender women ( 49 [32-86] ng/L) than in transgender men (17 [13-27] ng/L). Conclusions and RelevanceFindings of this cross-sectional study suggest that the differences in concentration for hs-cTn and NT-proBNP between transgender men and women were similar to what is observed between cisgender men and women. Sex hormones, rather than sex assigned at birth, may be a stronger driver of the observed concentration differences between healthy men and women for biomarkers of cardiac disease.
Details
- Title: Subtitle
- Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People
- Creators
- Dina N Greene - University of WashingtonRobert L Schmidt - University of UtahRobert H Christenson - University of Maryland, BaltimoreJessica Rongitsch - Kaiser Permanente Capitol Hill Medical CenterKatherine L Imborek - University of IowaHeather Rebuck - University of Maryland, BaltimoreThomas S Lorey - Kaiser Permanente Oakland Medical CenterAmy K Saenger - Hennepin County Medical CenterMatthew D Krasowski - University of Iowa
- Resource Type
- Journal article
- Publication Details
- JAMA cardiology, Vol.7(11), pp.1170-1174
- DOI
- 10.1001/jamacardio.2022.3299
- PMID
- 36197689
- PMCID
- PMC9535541
- ISSN
- 2380-6583
- eISSN
- 2380-6591
- Language
- English
- Date published
- 10/05/2022
- Academic Unit
- Pathology; Family and Community Medicine
- Record Identifier
- 9984305373702771
Metrics
9 Record Views